Suppr超能文献

抗金刚烷胺和奥司他韦耐药的人甲型 H1N1 流感病毒的遗传构成。

Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.

机构信息

Division of Public Health, Department of Infectious Disease Control and International Medicine, Niigata University, Graduate School of Medical and Dental Sciences, Niigata, Japan.

出版信息

J Clin Microbiol. 2010 Apr;48(4):1085-92. doi: 10.1128/JCM.01532-09. Epub 2010 Feb 3.

Abstract

The emergence and widespread occurrence of antiviral drug-resistant seasonal human influenza A viruses, especially oseltamivir-resistant A/H1N1 virus, are major concerns. To understand the genetic background of antiviral drug-resistant A/H1N1 viruses, we performed full genome sequencing of prepandemic A/H1N1 strains. Seasonal influenza A/H1N1 viruses, including antiviral-susceptible viruses, amantadine-resistant viruses, and oseltamivir-resistant viruses, obtained from several areas in Japan during the 2007-2008 and 2008-2009 influenza seasons were analyzed. Sequencing of the full genomes of these viruses was performed, and the phylogenetic relationships among the sequences of each individual genome segment were inferred. Reference genome sequences from the Influenza Virus Resource database were included to determine the closest ancestor for each segment. Phylogenetic analysis revealed that the oseltamivir-resistant strain evolved from a reassortant oseltamivir-susceptible strain (clade 2B) which circulated in the 2007-2008 season by acquiring the H275Y resistance-conferring mutation in the NA gene. The oseltamivir-resistant lineage (corresponding to the Northern European resistant lineage) represented 100% of the H1N1 isolates from the 2008-2009 season and further acquired at least one mutation in each of the polymerase basic protein 2 (PB2), polymerase basic protein 1 (PB1), hemagglutinin (HA), and neuraminidase (NA) genes. Therefore, a reassortment event involving two distinct oseltamivir-susceptible lineages, followed by the H275Y substitution in the NA gene and other mutations elsewhere in the genome, contributed to the emergence of the oseltamivir-resistant lineage. In contrast, amantadine-resistant viruses from the 2007-2008 season distinctly clustered in clade 2C and were characterized by extensive amino acid substitutions across their genomes, suggesting that a fitness gap among its genetic components might have driven these mutations to maintain it in the population.

摘要

抗病毒药物耐药季节性人甲型流感病毒(尤其是奥司他韦耐药 A/H1N1 病毒)的出现和广泛发生是主要关注点。为了了解抗病毒药物耐药 A/H1N1 病毒的遗传背景,我们对大流行前 A/H1N1 株进行了全基因组测序。分析了 2007-2008 年和 2008-2009 年流感季节在日本多个地区获得的季节性甲型流感 A/H1N1 病毒,包括抗病毒敏感病毒、金刚烷胺耐药病毒和奥司他韦耐药病毒。对这些病毒的全基因组进行测序,并推断每个个体基因组片段序列之间的系统发育关系。将流感病毒资源数据库中的参考基因组序列包括在内,以确定每个片段的最近祖先。系统发育分析表明,奥司他韦耐药株是由在 2007-2008 年流行的奥司他韦敏感重组株(2B 分支)进化而来,该株通过在 NA 基因中获得 H275Y 耐药性赋予突变而获得耐药性。奥司他韦耐药谱系(对应于北欧耐药谱系)代表了 2008-2009 年季节的 100%的 H1N1 分离株,并在聚合酶碱性蛋白 2(PB2)、聚合酶碱性蛋白 1(PB1)、血凝素(HA)和神经氨酸酶(NA)基因中进一步获得了至少一个突变。因此,涉及两个不同奥司他韦敏感谱系的重组事件,随后在 NA 基因中发生 H275Y 取代以及基因组其他部位的其他突变,促成了奥司他韦耐药谱系的出现。相比之下,2007-2008 年的金刚烷胺耐药病毒明显聚类在 2C 分支中,其基因组中广泛存在氨基酸取代,表明其遗传成分之间的适应性差距可能导致这些突变在人群中得以维持。

相似文献

1
Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.
J Clin Microbiol. 2010 Apr;48(4):1085-92. doi: 10.1128/JCM.01532-09. Epub 2010 Feb 3.
2
Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3.
6
Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
J Med Virol. 2013 Mar;85(3):379-87. doi: 10.1002/jmv.23482. Epub 2012 Dec 21.
8
Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan.
Emerg Infect Dis. 2010 Jun;16(6):926-35. doi: 10.3201/eid1606.091623.
9

引用本文的文献

1
Structural basis of different neutralization capabilities of monoclonal antibodies against H7N9 virus.
J Virol. 2025 Jan 31;99(1):e0140024. doi: 10.1128/jvi.01400-24. Epub 2024 Dec 20.
2
Secondary Structure of Influenza A Virus Genomic Segment 8 RNA Folded in a Cellular Environment.
Int J Mol Sci. 2022 Feb 23;23(5):2452. doi: 10.3390/ijms23052452.
4
Interleukin 16 Enhances the Host Susceptibility to Influenza A Virus Infection.
Front Microbiol. 2021 Sep 22;12:736449. doi: 10.3389/fmicb.2021.736449. eCollection 2021.
5
Conserved Structural Motifs of Two Distant IAV Subtypes in Genomic Segment 5 RNA.
Viruses. 2021 Mar 22;13(3):525. doi: 10.3390/v13030525.
6
Anti-Influenza Strategies Based on Nanoparticle Applications.
Pathogens. 2020 Dec 3;9(12):1020. doi: 10.3390/pathogens9121020.
8
Applying next-generation sequencing to unravel the mutational landscape in viral quasispecies.
Virus Res. 2020 Jul 2;283:197963. doi: 10.1016/j.virusres.2020.197963. Epub 2020 Apr 9.
9
Ceramide Suppresses Influenza A Virus Replication .
J Virol. 2019 Mar 21;93(7). doi: 10.1128/JVI.00053-19. Print 2019 Apr 1.
10
Investigating Different Mechanisms of Action in Combination Therapy for Influenza.
Front Pharmacol. 2018 Oct 23;9:1207. doi: 10.3389/fphar.2018.01207. eCollection 2018.

本文引用的文献

1
Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3.
2
3
Oseltamivir- and amantadine-resistant influenza viruses A (H1N1).
Emerg Infect Dis. 2009 Jun;15(6):966-8. doi: 10.3201/eid1506.081357.
4
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.
Emerg Infect Dis. 2009 Apr;15(4):552-60. doi: 10.3201/eid1504.181280.
5
Influenza virus resistance to antiviral agents: a plea for rational use.
Clin Infect Dis. 2009 May 1;48(9):1254-6. doi: 10.1086/598989.
6
Oseltamivir-resistant influenza a viruses circulating in Japan.
J Clin Microbiol. 2009 May;47(5):1424-7. doi: 10.1128/JCM.02396-08. Epub 2009 Mar 4.
7
The evolution of influenza resistance and treatment.
JAMA. 2009 Mar 11;301(10):1066-9. doi: 10.1001/jama.2009.324. Epub 2009 Mar 2.
8
Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.
JAMA. 2009 Mar 11;301(10):1042-6. doi: 10.1001/jama.2009.297. Epub 2009 Mar 2.
9
Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.
JAMA. 2009 Mar 11;301(10):1034-41. doi: 10.1001/jama.2009.294. Epub 2009 Mar 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验